Datasets:
timotheeplanes
/
doping

Dataset card Data Studio Files
xet
 Community
1
text
stringlengths
1
17.8k
If an ADO can conduct Sample collection in a virtual environment in the circumstances permitted by this Annex K, then the modified Sample collection procedures set out in this Annex, in particular complying with the additional standards referenced in Annex K.3.1 and K.3.2, are mandatory.
Additional guidance on how to implement several of the requirements outlined in this Annex are provided in the Guidelines for Testing During a Pandemic.]
K.2 ScopeThe procedure begins with the DCO notifying an Athlete at the testing location and handing the Athlete a package of Sample Collection Equipment and ends with the DCO collecting the sealed Sample and the corresponding Sample collection documentation from the Athlete at the location where notification to the Athlete of their selection for Testing and requirement to provide a Sample occurred, or at another location that the DCO and Athlete will agree to.
K.3 ResponsibilityK.3.1 In times of a pandemic and/or a national epidemic, all Anti -Doping Organizations shall followthe advice of national governments and health authorities to ensure the health and safety of Athletes and Sample Collection Personnel is protected.
Specific requi rements must be taken into consideration from any relevant international, national and regional laws when considering the implementation of Sample collection procedures (e.g., mandatory or recommended occupational health and safety practices such as social distancing, hand washing, mask wearing, vaccination etc.)
K.3.2 Prior to implementation, Anti-Doping Organizations shall assess modified Samplecollection procedures in a virtual environment, including any selected IT system and any Third- Party Agent involved in such procedures or IT system, against the requirements of the International Standard for the Protection of Privacy and Personal Information and applicable laws, such as privacy/data protection and if necessary, shall implement 1 As declared by the World Health Organization.
In addition, an ADO shall consider implementing the Sample collection in a virtual environment when the national government declares a national epidemic in a certain country or region.
ISTI – Effective 1 January 2023 Page 90 of 92 appropriate physical, organizational, technical, and other measures to mitigate privacy and information security risks identified in such assessment.
K.3.3 The DCO has the responsibility for providing the Athlete with instructions from the point ofthe in- person notification and then virtually via the IT system used, and that each Sample is properly collected, identified, documented, sealed, and the integrity of the Sample is maintained throughout the virtual coll ection and sealing process.
K.4 RequirementsK.4.1 When initial contact is made, the DCO shall inform the Athlete , at the testing location, thatthey are required to undergo a Sample collection.
The notification of the Athlete shall be in accordance with Article 5.4.1.
K.4.2 The DCO shall ensure that the Athlete is informed that the Sample collection and sealingprocedure will be conducted in a virtual environment during their Sample Collection Session, including any modifications as provided for in Annex A - Modifications for Athletes with Impairments and/or in Annex B - Modifications for A thletes who are Minors .
K.4.3 The DCO shall complete the ‘Athlete Notification’ part of the Sample collecti ondocumentation (either in paper or electronic) and the Athlete shall sign it to acknowledge and accept the notification.
If the Athlete refuses to sign that they have been notified, or evades the notification, the DCO shall, if possible, inform the Athlete of the Consequences of a Failure to Comply.
The DCO shall document the facts in a detailed report and report the circumstances to the Testing Authority .
The Testing Authority shall follow the steps prescribed in Annex A - Review of a Possible Failure to Comply of the International Standard for Results Management .
K.4.4 The DCO shall start a two -way video and audio connection via the selected IT system (e.g.,tablet, mobile phone, or body camera) with supporting mounting device (if applicable) and provide it to the Athlete .
The DCO shall advise the Athlete that they must remain on camera with the DCO via the IT system for the duration of the Sample Collection Session.
The DCO shall also inform the Athlete that recording functions have been completely disabled.
K.4.5 The DCO shall then provide the Athlete with the package that includes Sample CollectionEquipment, other supporting devices such as temperature monitoring strips, and applicable documentation.
The DCO shall inform the Athlete to proceed with the Sample Collection Equipment to a suitable Sample collection location that is private and where the Sample Collection Session can continue.
The DCO shall also ensure they are in a private location.
K.4.6 When the Athlete is positioned in the Sample Collection location where the Sampl eCollection Session will be conducted, the DCO , connected virtually via the IT system, shall instruct the Athlete to: a)Confirm if an Athlete representative is present with the Athlete in the Sample Collectionlocation;b)Show the DCO on camera via the IT system the Sample Collection location selectedwhere the Sample Collection Session will be conducted; andc)Confirm satisfactory audio and visual quality of the IT system used.ISTI – Effective 1 January 2023 Page 91 of 92 K.4.7 The DCO shall confirm to the Athlete that the DCO will also be on camera for the durationof the Sample Collection Session and that the Sample Collection Session is not being recorded.
K.4.8 The DCO shall then ask the Athlete to place the IT system in a location where the DCOwill have a view of the Athlete (including upper body and hands) and have full view of the Sample Collection Equipment .
K.4.9 The Athlete shall place the content of the package with the Sample Collection Equipment ,supporting devices and documentation on a steady surface in the Sample collection location in full view of the DCO .
K.4.10 The Athlete shall complete the ‘ Athlete Information’ part of the Sample collectiondocumentation (either in paper or electronic) with the assistance of the DCO .
K.4.11 The DCO shall instruct the A thlete to select a collection vessel in accordance with AnnexC.4.3.
The DCO shall then ask the Athlete to apply a temperature monitoring strip to theoutside of the collection vessel.K.4.12 When the Athlete is ready to provide a urine Sample, the DCO shall ask the Athlete tomove to the toilet area and show the DCO on camera the toilet area in which they will be providing their Sample.
The DCO should direct the Athlete as to the best location for the IT system to be positioned during the Sample provision.
Anything suspicious e.g., other urine Samples or doping paraphernalia in the toilet area with potential to compromise the Sample collection shall be documented in detail by the DCO .
K.4.13 The DCO shall also inform the Athlete that Sample provision will not be directly witnessedas it normally would be, i.e., the DCO observing the urine Sample directly leaving their body, however, the Athlete will be continuously observed via the IT system in the toilet area.
The camera shall be set in a position in the toilet area that provides the DCO with a full view of the Athlete’s upper body (i.e., waist to top of head) and arms while they are waiting to provide a Sample and/or during the Sample provision.
K.4.14 The Athlete shall be reminded of the importance to stay on camera during the sampl eprovision and be advised of the possible Consequences of a Failure to Comply .
Any loss of connection should be documented including exact time and duration, as well as any further re- connection attempts and explanations from the Athlete .
If the Athlete does not remain visible in the camera field of view or the Sample once provided by the Athlete does not remain visible in the camera field of view and i f the circumstances are deemed suspicious by the DCO , the DCO shall consider collecting an additional Sample from the Athlete.
The DCO shall document the facts in a detailed report and report the circumstances to the Testing Authority .
[Comment to K.4.12 and K.4.14: If appropriate, the Testing Authority shall follow the steps prescribed in Annex A - Review of a Possible Failure to Comply in the International Standard for Results Management.]
K.4.15 Once the Athlete provides the required volume of urine, the DCO shall ask the Athlete toshow them the collection vessel with the volume measurement scale on camera to validate that the Suitable Volume of Urine for Analysis has been provided.
Where the volume of urine provided by the Athlete is insufficient, the DCO shall provide instructions to the Athlete ISTI – Effective 1 January 2023 Page 92 of 92 to follow the partial Sample collection procedure in accordance with Annex E - Urine Sample – Insufficient Volume.
K.4.16 Once the lid of the collection vessel has been secured, the DCO shall then ask the Athletewhilst in the toilet area to show the temperature monitoring strip measurement on camera to allow the DCO to confirm the temperature of the urine Sample .
K.4.17 The Athlete shall exit the toilet area and return to the Sample collection location, ensuringthey keep their Sample visible on camera.
On return to the Sample collection location, the Athlete shall position the camera in the same location as it was at the start of the procedure so that their Sample are in full view of the DCO until the Sample is sealed.
K.4.18 The DCO shall guide the Athlete through the process of selecting and opening a Sampl ecollection kit containing A and B bottles in accordance with Annex C.4.3 and Annex C.4.12.
The Athlete shall show the DCO the Sample code numbers and the DCO should document them (and later confirm upon receipt of the Sample ).
K.4.19 The division of the Sample into the A and B bottles and the sealing of the A and B bottlesshall be conducted by the Athlete in full view of the DCO in accordance with Annex C.4.13 and C.4.14.
K.4.20 Once the Athlete has finished the sealing of the A and B bottles, the Athlete shall test theresidual urine in the collection vessel to determine if the Sample has a Suitable Specific Gravity for Analysis with the assistance of the DCO.
When the urine Sample does not meet the requirement for Suitable Specific Gravity for Analysis , the DCO shall provide instructions to the Athlete to follow the appropriate procedures in accordance with Annex F - Urine Samples that do not meet the requirement for Suitable Specific Gravity for Analysis .
K.4.21 The Athlete shall complete the Sample collection documentation with the assistance of theDCO .
The Athlete and the DCO shall sign appropriate documentation to indicate their satisfaction that the documentation accurately reflects the details of the Sample Collection Session.
The DCO shall ensure that the Athlete is advised to keep a copy of the Sample collection documentation (if in paper) or that the Athlete receives a copy of the Sample collection documentation (if electronic).
K.4.22 Upon completion, the DCO shall ask the Athlete to pack their Sample , all Sample CollectionEquipment and documentation and meet the DCO in the initial location where the Athlete was notified or an agreed upon location.
K.4.23 The Athlete shall remain on camera until they have concluded the Sample CollectionSession, and they meet the DCO in-person.
K.4.24 The DCO, upon receiving the requested equipment and documentation from the Athlete ,shall c onduct a review of all Sample Collection Equipment, supporting devices and documentation, and confirm, in writing, that Sample collection documentation and corresponding Sample(s) are enclosed.
Page 1 of 10 PROACTIVE REPORTING POLICY September 2023 International Testing Agency, Avenue de Rhodanie 40B, 1007 Lausanne, Switzerland Phone: +41 (0)21 612 12 12 | Email: info@ita.sport | Web: www.ita.sport Page 2 of 10 TABLE OF CONTENTS 1.
INTRODUCTION ................................ ................................ ................................ .................. 3 2.
SCOPE ................................ ................................ ................................ ................................ .
4 3.
SOURCES OF ANTI -DOPING REPORTING ................................ ................................ .......... 4 4.
WHAT TYPE OF ANTI -DOPING INFORMATION CAN BE REPORTED TO THE ITA ............... 4 5.
CHANNELS FOR REPORTING ANTI -DOPING INFORMATION TO THE ITA ........................ 5 6.
HOW ANTI -DOPING INFORMATION IS PROCESSED BY THE ITA ................................ ...... 6 7.
TRANSFER OF INFORMATION TO OTHER ENTITIES ................................ ............................. 8 8.
PROTECTION AND REWARDS AVAILABLE TO PROACTIVE REPORTERS ........................... 8 9.
OBLIGATIONS OF THE PROACTIVE REPORTER AND ABUSE OF THE PROACTIVE REPORTING SYSTEM ................................ ................................ ................................ ............ 9 10.
PERSONAL INFORMATION AND DATA PRIVACY ................................ ........................... 10 Page 3 of 10 INTRODUCTION The International Testing Agency (“ITA”) is an international organisation constituted as a not -for-profit foundation, based in Lausanne, Switzerland.
Its mission is to deliver comprehensive anti-doping program mes, in an independent and impartial manner, to International Federations (“IFs”), Major Event Organisers (“MEOs”), and other Anti -Doping Organisations (“ADOs”) requesting and/or requiring support.
Pursuant to the World Anti -Doping Code ( “the Code”) and the World Anti -Doping Agency (“WADA”)’s Inte rnational Standard for Testing and Investigations (“ISTI”), ADOs must have the capability to obtain, assess and process anti -doping intelligence from all available sources in order to help deter and detect doping1, to inform the development of an effectiv e and proportionate test distribution plan2, and/or to form the basis of an investigation into possible anti -doping rule violations (“ADRV s”).3 The purpose of an anti -doping programme is to protect athletes’ health and right to a fair environment by deterring and catching those individuals who dope with prohibited substances or prohibited methods.
While testing remains an integral element of a ny anti -doping programme, testing alone is not sufficient for establishing all anti -doping rule violations.
In recent years, ADRVs have been increasingly uncovered on the basis of intelligence processes and investigations.
The role of Proactive Reports has proven to be a major and impactful impetus in the reporting, investigation , and prosecution of anti -doping rule violations and in the broader pursuit of clean sport.
It is therefore vital that athletes and sports actors in general feel confident to report, trust the organisation to whom they are reporting, and are provided with the opportunity to confidently report any breach or suspected breach of the Code in a secure, confidential, and (if they so wish) anonymous manner.
It should be noted that the ITA manages and operates anti-doping programmes independently of sport ing and political powers .
In addition, the ITA also manages intelligence & investigation operations – including its Proactive Reporting initiatives – in full autonomy and independently of the relevant IF or MEO and has no obligation to report the identity of Proactive Reporters to them .
In furtherance of its statutory objectives to protect clean athletes and the integrity of sport through the fight against do ping4, the ITA has established secure and confidential Proactive Reporting system s named “REVEAL ” (see Section 5) to empower and encourage individuals to report any suspicion of an y potential ADRVs , particularly for th ose sports whose anti-doping programme s are managed and implemented by the ITA .
The ITA recogni ses the value of reporting doping allegations and is committed to impartiality and trustworthiness by ensuring that all individuals have the ability and confidence to come forw ard and REVEAL information that may lead to the uncovering of doping violations.
The ITA therefore encourages individuals to come forward and disclose anti -doping information to help protect athletes and to continue to Keep Sport Real.
1 See ISTI 11.2.1 2 See ISTI 11.4.1 3 See ISTI 11.3.2 4 See Article 4 of the ITA Statutes ( ita.sport/resource/ita -statutes/ ) Page 4 of 10 SCOPE This Proactive Reporting Policy (hereinafter : the “Policy”) has been developed by the ITA as part of its mandate to manage confidential anti-doping reporting operations on behalf of a number of partner IFs and MEOs, in compliance with the Code and WADA’s International Standards and in furtherance of the ITA’s objectives as stipulated in Article 4 of the ITA Statutes.
The list of sports and/or events for which the ITA operates the anti -doping programmes is published on the ITA’s website and in the ITA’s confidential reporting platform s “REVEAL ”.
Any infor mation transmitted to the ITA via any form or fashion pertaining to sports whose anti-doping programmes are not managed by the ITA may be transmitted to other relevant ADOs (when those organi sations are not the subject or target of the allegations ), WADA, law enforcement and/or public authorities as relevant .
The protection of the identity of the Proactive Reporter is at the heart of the ITA’s intelligence & investigations work .
Unless prior consent is given, or where required by law, information that has the potential to identify the Proactive Reporter will not be transmitted outside of the ITA.
Further, the ITA will endeavour to obtain consent fr om the Proactive Reporter, where possible, in the pursuit of transfer of information outside of the ITA's scope.
For further information on the transfe r of information to other entities please refer to Section 7 below.
This Policy outlines how information concerning potential ADRVs may be transmitted to the ITA via secure and confidential reporting channel s, and how such information would be securely ha ndled by the ITA.
SOURCES OF ANTI -DOPING REPORTING Anyone – whether an athlete, athlete support personnel, doping control personnel, sports official or otherwise – who has become aware of or has reason to suspect any activity, behaviour or circumstance that may be indicative of an ADRV , may , depending on the circumstances, be required to disclose this information t o the relevant ADO .
In any event, everyone suspecting wrongdoing or in posse ssion of information is encouraged to submit a report to the ITA .
For the purpose s of this Policy, any person who reports anti -doping information to the ITA is referred to as a “ Proactive Report er”.
WHAT TYPE OF ANTI -DOPING INFORMATION CAN BE REPORTED TO THE ITA Reporting may touch upon any of the following categories listed below .
This list is , however , not exhaustive : • Use of a prohibited substance or a prohibited method1 • Administration of a prohibited substance or a prohibited method • Tampering with or evading doping control5 • Trafficking of prohibited substances • Possession of prohibited substances • Suspicious w hereabouts • Suspicious performance • Suspicious behaviour • Acts to discourage or retaliate against reporting anti -doping information • Prohibited association with banned individuals 5 The list of prohibited substances and prohibited methods can be found at https://www.wada - ama.org/en/content/what -is-prohibited Page 5 of 10 • Complicity in the above categories All information or suspicions, no matter how seemingly insignificant or unimportant, have value and could be decisive in uncovering ADRVs .
It is thus important that any and all anti -doping information is reported and described in as much detail and with as much concrete supporting information as possible.
Any potential evidence is welcomed, including but not limited to video s, pictures, audio, text messages, etc.
Please note that any reported information does not need to be able to prove that an ADRV has occurred.
For clarity, the establishment of an ADRV remains the responsibility of the ITA or the relevant ADO.
Any information transmitted to the ITA that does no t fall in to the above categories and that is not relevant for anti -doping purposes may, depending on the circumstances, be transmitted to other relevant sports organi sations, law enforcement and/or public authorities .
Such information is treated in the sam e stringent confidential manner as any anti-doping related intelligence as set forth in this Policy and further detailed under Section 7 below.
CHANNELS FOR REPORTING ANTI -DOPING INFORMATION TO THE ITA The ITA has established secure platform s named REVEAL for the confidential and encrypted reporting of information.
The reporting platform s are developed and provided by industry -leading international compliance and Proactive Reporting service s. The online reporting platform is provided by EQS Integrity Line6, with REVEAL being exclusive to the ITA , while the anonymous email, text and WhatsApp communication platforms are provided by RealResponse .7 Proactive Reporters have two options to submit confidential information: (1) directly via the REVEAL online platform; or (2) via the anonymous email, text and/or WhatsApp reporting platforms.
The security and confidentiality of the information provided is of the utmost importance to the ITA, which is why we recommend that Proactive Reporters opt for submitting information via the suite of REVEAL platform s. All reports received through the REVEAL platforms are confidential.
When reporting, the ITA prefers that Proactive Reporters share their identity with the intelligence experts within the ITA Intelligence & Investigations Department , as it enables more fulsome communication and the potential to provide feedback to the Proactive Reporter on any ensuing investigations .
However, Proact ive Reporters can elect to remain anonymous if they wish.